Additionally, and in accordance with the in vitro assays, the effectiveness in vivo of HpI4 on reducing HER-2 protein levels was greater than that of HpI6, even though both PPRHs caused a significant reduction in tumor growth. The gene discussed is ERBB2; the disease is neoplasm.